Developer docs
API playgroundTry for free, no card

Search company profiles

Integer Holdings

Full company profile

uuid0002ygy

Namestring
Integer Holdings
Legal namestring
Integer Holdings Corporation
Company typeenum
Public
Founded yearint
2000
Descriptiontext

Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device contract development and manufacturing organizations (CDMOs) globally, with 11,000+ associates across 25+ facilities in the U.S., Mexico, Dominican Republic, Uruguay, Ireland, Switzerland, and Malaysia. Founded in 1946 and headquartered in Plano, TX, the company operates through two primary sub-brands (Greatbatch Medical and Lake Region Medical) and serves medical device OEMs across cardiac rhythm management, cardio and vascular, neuromodulation, and portable power markets. Integer designs, develops, and manufactures Class III implantable medical devices, components, and sub-assemblies — including implantable pulse generators, lead systems, catheters, guidewires, batteries, capacitors, feedthroughs, and complex braided biomaterial structures — for named enterprise customers such as Medtronic and Boston Scientific. Its proprietary technology portfolio includes Xcellion Gen 3 fast-charge lithium-ion batteries, O-PTFE Filmcast Liner technology, TiN and IrOx electrode coatings, QCAPS high-energy tantalum capacitors, the 5cc mSTIM IPG platform, and complex Nitinol/wire braiding capabilities, protected by registered trademarks and U.S. patents.

The company generates revenue primarily through B2B contract manufacturing services on a quote-based pricing model under multi-year OEM contracts, complemented by off-the-shelf market-ready products (510(k) and CE Mark registered) and custom battery solutions via the Electrochem brand. Integer monetizes its vertically integrated supply chain — spanning design, prototyping, manufacturing, coatings, and sterilization — through a direct enterprise sales motion targeting OEM engineering and procurement teams. The R&D Velocity ecosystem connects design, prototyping, and manufacturing to reduce OEM development timelines and de-risk product commercialization. Historical revenue growth has come from a combination of organic expansion and a sustained M&A program that has added capabilities in neurovascular catheters (InNeuroCo, 2023), precision machining (Pulse Technologies, 2024), parylene and surface coatings (VSi Parylene, 2025), and medical textiles (Aran Biomedical, 2022). In April 2026, the Board initiated a strategic review exploring potential sale, merger, or other strategic combinations following a flat Q1 2026 and securities litigation alleging electrophysiology business deterioration.

Short descriptiontext

Integer Holdings (NYSE: ITGR) is one of the largest pure-play medical device CDMOs globally, designing and manufacturing Class III implantable devices, components, and sub-assemblies for OEMs like Medtronic and Boston Scientific across cardiac rhythm, cardio & vascular, and neuromodulation markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersWilmington, United States
HQ citystring
Wilmington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices24 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device outsourcing, contract manufacturing services, cardiac rhythm management, cardio and vascular devices, neuromodulation components
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Medical Device Contract Manufacturing
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Contract Development and Manufacturing Services
TypeHardware Sales
Description

Full-service CDMO providing design, development, and manufacturing services for medical device components and finished systems. Revenue derived from long-term contracts with major medical device OEMs across multiple therapy areas including cardiac rhythm management, cardio and vascular, and neuromodulation

integer.net
2Market-Ready Products
TypeHardware Sales
Description

Off-the-shelf, regulatory-approved guidewires, introducers, steerable sheaths, and biopsy forceps providing quick market access for medical device OEMs

integer.net
3Custom Battery Design and Manufacturing
TypeHardware Sales
Description

Cell and custom battery pack design, development and manufacturing for implantable and external medical device applications through Electrochem brand

integer.net
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details1 tier
1Custom contract manufacturing services - pricing based on individual customer requirements
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based / Not publicly disclosed

integer.net
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1QCAPS (Greatbatch Medical)
Description

High energy wet tantalum capacitors for tachycardia devices

integer.net
+4 more records
Core offering1 text field

Integer Holdings is a medical device contract development and manufacturing organization (CDMO) that designs, develops, and manufactures components, sub-assemblies, and finished Class III medical device systems for medical device OEMs. The company serves cardiac rhythm management, cardio and vascular, neuromodulation, and portable power markets with proprietary technologies such as Xcellion batteries, O-PTFE liners, TiN/IrOx coated electrodes, and complex Nitinol braiding, along with market-ready 510(k) and CE Mark registered products.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 8% year-over-year revenue growth in 2025 to $1.854 billion
+3 more records
Product overview1 text field

Integer Holdings Corporation operates as one of the world's largest medical device contract development and manufacturing organizations (CDMOs), serving the cardio and vascular, neuromodulation, and cardiac rhythm management markets. The company's portfolio spans a unified platform of components, sub-assemblies, and finished medical devices, organized under two primary sub-brands: Greatbatch Medical® and Lake Region Medical®. The product portfolio includes: capacitors (QCAPS® High Energy Wet Tantalum Capacitors), implantable batteries, catheters (diagnostic, ablation, steerable), Class III Medical Device Systems (implantable pulse generators via the 5cc mSTIM IPG platform, lead systems), steerable catheters/sheaths/delivery systems, guidewires (angiographic, coronary, peripheral, neurovascular), introducers, IPG components, lead components, medical coatings (PTFE, Hydrophilic, Parylene, Ion Implantation, IBAD, Surface Texturizing), medical textiles (knitted, woven, braided), O-PTFE Filmcast Liner Technology, coronary and peripheral vascular stents, thin wall tubing/composite tubing/coated wire, feedthroughs, complex braiding and formed biomedical structures, and market-ready off-the-shelf products. Integer offers end-to-end solutions from concept to production, including R&D Velocity (rapid prototyping and design services), vertically integrated supply chain, and regulatory compliance support.

Product and service16 records
1QCAPS High Energy Wet Tantalum Capacitors
CategoryComponents - Capacitors
2Implantable Batteries
CategoryComponents - Batteries
3Catheters
CategoryComponents / Finished Devices - Catheters
4Class III Medical Device Systems
CategoryFinished Devices - Class III Systems
5Steerable Catheters, Sheaths & Delivery Systems
CategoryFinished Devices - Delivery Systems
6Guidewires
CategoryComponents / Finished Devices - Guidewires
7Introducers
CategoryFinished Devices - Introducers
8IPG Components
CategoryComponents - IPG
9Lead Components
CategoryComponents - Leads
10Medical Coatings
CategoryTechnology / Service - Coatings
11Medical Textiles
CategoryComponents - Textiles
12Coronary & Peripheral Vascular Stents
CategoryComponents / Finished Devices - Stents
13Thin Wall Tubing, Composite Tubing & Coated Wire
CategoryComponents - Tubing
14Unfiltered & Filtered Feedthroughs
CategoryComponents - Feedthroughs
15Complex Braiding and Formed Biomedical Structures
CategoryComponents / Technology - Braiding
16Market-Ready Products
CategoryOff-the-shelf Products
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-11
Description

Integer acquired Pulse Technologies for $140 million in January 2024. The acquisition expanded Integer's precision machining and complex manufacturing capabilities, adding operations in Quakertown West, PA with AS9100D certification for aerospace-grade manufacturing.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Jabil Healthcare is one of the largest contract manufacturers of medical devices, providing design, engineering, and manufacturing services for OEMs in diagnostics, surgical, and connected health. It is a direct comparable to Integer as a scaled, public medical device CDMO serving similar OEM customers across therapeutic and diagnostic categories.

TypeDirect peer
Description

Flex's Health Solutions business provides design, manufacturing, and supply chain services for medical devices, diagnostics, and connected health products for OEMs globally. Comparable to Integer as a large diversified EMS/CDMO with a dedicated medical-device vertical serving Fortune 500 medtech OEMs.

TypeDirect peer
Description

Sanmina operates a Medical division providing integrated manufacturing solutions for medical devices, diagnostics, and imaging systems. Directly comparable to Integer as a mid-to-large medical-device-focused contract manufacturer with similar OEM customer base and regulatory capabilities.

TypeDirect peer
Description

Celestica's HealthTech segment manufactures complex medical devices, diagnostics, and imaging equipment for global OEMs. Directly comparable to Integer as a public North American CDMO serving similar regulated medical-device end markets with analogous services from design to manufacturing.

TypeBroad incumbent
Description

TE Connectivity supplies connectors, sensors, and components used extensively in medical devices including implantable and diagnostic equipment. Comparable as a broad incumbent with significant medical exposure, overlapping with Integer's component business but serving a wider set of end markets beyond medical devices.

TypeBroad incumbent
Description

West Pharmaceutical Services is a global leader in injectable drug containment and delivery, with growing CDMO capabilities. Comparable as a larger incumbent in regulated healthcare contract manufacturing with deep OEM relationships, though its primary focus on primary packaging and drug delivery differs from Integer's device emphasis.

TypeDirect peer
Description

Cirtec Medical is a privately held medical device CDMO specializing in neuromodulation, active implantable devices, and minimally invasive surgical components. Highly comparable to Integer as a focused medical device CDMO competing for similar outsourced manufacturing of implantable and Class III systems.

TypeDirect peer
Description

SteriPack is a contract manufacturer of medical devices and combination products with strong design, packaging, and sterilization capabilities. Directly comparable to Integer as a smaller-scope CDMO serving medical device OEMs, though more focused on packaging and sterile barrier solutions than implants.

TypeBroad incumbent
Description

Nordson Medical designs and manufactures precision components and devices for interventional, electrophysiology, and other medical applications. Comparable as a broader incumbent in medical component manufacturing with meaningful overlap in catheters, balloons, and delivery systems, complementing Integer's finished-device and component portfolio.

TypeEmerging player
Description

Minnetronix Medical is a privately held medical device CDMO focused on complex active implantable and energy-based therapeutic devices. Comparable to Integer as a focused medical device CDMO competing for similar OEM outsourced manufacturing work, though materially smaller in scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries6 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A7 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Integer Holdings

Medical Device Contract Manufacturinginteger.net

Integer Holdings (NYSE: ITGR) is one of the largest pure-play medical device CDMOs globally, designing and manufacturing Class III implantable devices, components, and sub-assemblies for OEMs like Medtronic and Boston Scientific across cardiac rhythm, cardio & vascular, and neuromodulation markets.

What Integer Holdings does

Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device contract development and manufacturing organizations (CDMOs) globally, with 11,000+ associates across 25+ facilities in the U.S., Mexico, Dominican Republic, Uruguay, Ireland, Switzerland, and Malaysia. Founded in 1946 and headquartered in Plano, TX, the company operates through two primary sub-brands (Greatbatch Medical and Lake Region Medical) and serves medical device OEMs across cardiac rhythm management, cardio and vascular, neuromodulation, and portable power markets. Integer designs, develops, and manufactures Class III implantable medical devices, components, and sub-assemblies — including implantable pulse generators, lead systems, catheters, guidewires, batteries, capacitors, feedthroughs, and complex braided biomaterial structures — for named enterprise customers such as Medtronic and Boston Scientific. Its proprietary technology portfolio includes Xcellion Gen 3 fast-charge lithium-ion batteries, O-PTFE Filmcast Liner technology, TiN and IrOx electrode coatings, QCAPS high-energy tantalum capacitors, the 5cc mSTIM IPG platform, and complex Nitinol/wire braiding capabilities, protected by registered trademarks and U.S. patents.

The company generates revenue primarily through B2B contract manufacturing services on a quote-based pricing model under multi-year OEM contracts, complemented by off-the-shelf market-ready products (510(k) and CE Mark registered) and custom battery solutions via the Electrochem brand. Integer monetizes its vertically integrated supply chain — spanning design, prototyping, manufacturing, coatings, and sterilization — through a direct enterprise sales motion targeting OEM engineering and procurement teams. The R&D Velocity ecosystem connects design, prototyping, and manufacturing to reduce OEM development timelines and de-risk product commercialization. Historical revenue growth has come from a combination of organic expansion and a sustained M&A program that has added capabilities in neurovascular catheters (InNeuroCo, 2023), precision machining (Pulse Technologies, 2024), parylene and surface coatings (VSi Parylene, 2025), and medical textiles (Aran Biomedical, 2022). In April 2026, the Board initiated a strategic review exploring potential sale, merger, or other strategic combinations following a flat Q1 2026 and securities litigation alleging electrophysiology business deterioration.

Integer Holdings firmographics

Firmographics
Name
Integer Holdings
Legal name
Integer Holdings Corporation
Website
https://www.integer.net
Company type
Public
Founded year
2000
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Integer Holdings (NYSE: ITGR) is one of the largest pure-play medical device CDMOs globally, designing and manufacturing Class III implantable devices, components, and sub-assemblies for OEMs like Medtronic and Boston Scientific across cardiac rhythm, cardio & vascular, and neuromodulation markets.
Ownership category
akta.pro rank

Where Integer Holdings is headquartered

Location

Headquarters

HQ city
Wilmington
HQ country
United States
HQ region
North America

Offices24 records

Markets served

Integer Holdings business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Contract Development and Manufacturing Services: Full-service CDMO providing design, development, and manufacturing services for medical device components and finished systems. Revenue derived from long-term contracts with major medical device OEMs across multiple therapy areas including cardiac rhythm management, cardio and vascular, and neuromodulation
  2. Market-Ready Products: Off-the-shelf, regulatory-approved guidewires, introducers, steerable sheaths, and biopsy forceps providing quick market access for medical device OEMs
  3. Custom Battery Design and Manufacturing: Cell and custom battery pack design, development and manufacturing for implantable and external medical device applications through Electrochem brand

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom contract manufacturing services - pricing based on individual customer requirements

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Integer Holdings product offering

Product offering

Core offering

Integer Holdings is a medical device contract development and manufacturing organization (CDMO) that designs, develops, and manufactures components, sub-assemblies, and finished Class III medical device systems for medical device OEMs. The company serves cardiac rhythm management, cardio and vascular, neuromodulation, and portable power markets with proprietary technologies such as Xcellion batteries, O-PTFE liners, TiN/IrOx coated electrodes, and complex Nitinol braiding, along with market-ready 510(k) and CE Mark registered products.

Product overview

Integer Holdings Corporation operates as one of the world's largest medical device contract development and manufacturing organizations (CDMOs), serving the cardio and vascular, neuromodulation, and cardiac rhythm management markets. The company's portfolio spans a unified platform of components, sub-assemblies, and finished medical devices, organized under two primary sub-brands: Greatbatch Medical® and Lake Region Medical®. The product portfolio includes: capacitors (QCAPS® High Energy Wet Tantalum Capacitors), implantable batteries, catheters (diagnostic, ablation, steerable), Class III Medical Device Systems (implantable pulse generators via the 5cc mSTIM IPG platform, lead systems), steerable catheters/sheaths/delivery systems, guidewires (angiographic, coronary, peripheral, neurovascular), introducers, IPG components, lead components, medical coatings (PTFE, Hydrophilic, Parylene, Ion Implantation, IBAD, Surface Texturizing), medical textiles (knitted, woven, braided), O-PTFE Filmcast Liner Technology, coronary and peripheral vascular stents, thin wall tubing/composite tubing/coated wire, feedthroughs, complex braiding and formed biomedical structures, and market-ready off-the-shelf products. Integer offers end-to-end solutions from concept to production, including R&D Velocity (rapid prototyping and design services), vertically integrated supply chain, and regulatory compliance support.

Differentiator

Problem solved

Functional benefit

Brands

  • QCAPS (Greatbatch Medical): High energy wet tantalum capacitors for tachycardia devices
  • Xcellion (Batteries)
  • R&D Velocity
  • ATAR (Medical Coatings)
  • O-PTFE Filmcast Liner Technology

Products and services

  • QCAPS High Energy Wet Tantalum Capacitors
  • Implantable Batteries
  • Catheters
  • Class III Medical Device Systems
  • Steerable Catheters, Sheaths & Delivery Systems
  • Guidewires
  • Introducers
  • IPG Components
  • Lead Components
  • Medical Coatings
  • Medical Textiles
  • Coronary & Peripheral Vascular Stents
  • Thin Wall Tubing, Composite Tubing & Coated Wire
  • Unfiltered & Filtered Feedthroughs
  • Complex Braiding and Formed Biomedical Structures
  • Market-Ready Products

Quantifiable outcome

  • 8% year-over-year revenue growth in 2025 to $1.854 billion
  • +3 more outcomes

Companies that use Integer Holdings

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles2 records

Integer Holdings technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Integer Holdings partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Pulse TechnologiescoreStrategic or Co-development Partner · 11 January 2024Integer acquired Pulse Technologies for $140 million in January 2024. The acquisition expanded Integer's precision machining and complex manufacturing capabilities, adding operations in Quakertown West, PA with AS9100D certification for aerospace-grade manufacturing.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Integer Holdings competitors and assessment

Company assessment

Direct peers

  • Jabil: Jabil Healthcare is one of the largest contract manufacturers of medical devices, providing design, engineering, and manufacturing services for OEMs in diagnostics, surgical, and connected health. It is a direct comparable to Integer as a scaled, public medical device CDMO serving similar OEM customers across therapeutic and diagnostic categories.
  • Flex Ltd: Flex's Health Solutions business provides design, manufacturing, and supply chain services for medical devices, diagnostics, and connected health products for OEMs globally. Comparable to Integer as a large diversified EMS/CDMO with a dedicated medical-device vertical serving Fortune 500 medtech OEMs.
  • Sanmina Corporation: Sanmina operates a Medical division providing integrated manufacturing solutions for medical devices, diagnostics, and imaging systems. Directly comparable to Integer as a mid-to-large medical-device-focused contract manufacturer with similar OEM customer base and regulatory capabilities.
  • Celestica Inc. Celestica's HealthTech segment manufactures complex medical devices, diagnostics, and imaging equipment for global OEMs. Directly comparable to Integer as a public North American CDMO serving similar regulated medical-device end markets with analogous services from design to manufacturing.
  • Cirtec Medical: Cirtec Medical is a privately held medical device CDMO specializing in neuromodulation, active implantable devices, and minimally invasive surgical components. Highly comparable to Integer as a focused medical device CDMO competing for similar outsourced manufacturing of implantable and Class III systems.
  • SteriPack Group: SteriPack is a contract manufacturer of medical devices and combination products with strong design, packaging, and sterilization capabilities. Directly comparable to Integer as a smaller-scope CDMO serving medical device OEMs, though more focused on packaging and sterile barrier solutions than implants.

Broad incumbents

  • TE Connectivity: TE Connectivity supplies connectors, sensors, and components used extensively in medical devices including implantable and diagnostic equipment. Comparable as a broad incumbent with significant medical exposure, overlapping with Integer's component business but serving a wider set of end markets beyond medical devices.
  • West Pharmaceutical Services: West Pharmaceutical Services is a global leader in injectable drug containment and delivery, with growing CDMO capabilities. Comparable as a larger incumbent in regulated healthcare contract manufacturing with deep OEM relationships, though its primary focus on primary packaging and drug delivery differs from Integer's device emphasis.
  • Nordson Corporation: Nordson Medical designs and manufactures precision components and devices for interventional, electrophysiology, and other medical applications. Comparable as a broader incumbent in medical component manufacturing with meaningful overlap in catheters, balloons, and delivery systems, complementing Integer's finished-device and component portfolio.

Emerging players

  • Minnetronix Medical: Minnetronix Medical is a privately held medical device CDMO focused on complex active implantable and energy-based therapeutic devices. Comparable to Integer as a focused medical device CDMO competing for similar OEM outsourced manufacturing work, though materially smaller in scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Integer Holdings social profiles

Digital presence

Integer Holdings financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Integer Holdings leadership team

Management profile

Number of profiles

Profiles9 records

Integer Holdings subsidiaries and ownership

Company hierarchy

Subsidiaries6 records

Integer Holdings funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Integer Holdings M&A and investment

M&A and investment

M&A7 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Integer Holdings

What does Integer Holdings do?

Integer Holdings is a medical device contract development and manufacturing organization (CDMO) that designs, develops, and manufactures components, sub-assemblies, and finished Class III medical device systems for medical device OEMs. The company serves cardiac rhythm management, cardio and vascular, neuromodulation, and portable power markets with proprietary technologies such as Xcellion batteries, O-PTFE liners, TiN/IrOx coated electrodes, and complex Nitinol braiding, along with market-ready 510(k) and CE Mark registered products.

Is Integer Holdings a public or private company?

Integer Holdings is a public company. It is classified as public and is currently operating.

When was Integer Holdings founded?

Integer Holdings was founded in 2000. It employs 5,001 to 10,000 people.

Where is Integer Holdings based?

Integer Holdings is headquartered in Wilmington, United States, in the North America region.

How does Integer Holdings make money?

Three revenue lines are on record. Contract Development and Manufacturing Services are the primary driver. The others are market-Ready Products and custom Battery Design and Manufacturing.

Who are Integer Holdings's main competitors?

Direct peers on record are Jabil, Flex Ltd, Sanmina Corporation, Celestica Inc., Cirtec Medical and SteriPack Group. Broad incumbents are TE Connectivity, West Pharmaceutical Services and Nordson Corporation. Minnetronix Medical is listed as an emerging player.

Does Integer Holdings have an API?

No public API is recorded for Integer Holdings.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinancialContent Business Page1 Healthcare Stock with Competitive Advantages and 2 We Find RiskyThe article evaluates three healthcare stocks, recommending Pfizer for its durable advantage and warning against Danaher and Integer Holdings. Pfizer trades at 9.9x forward P/E, while Danaher and Integer show underperformance and slower growth. The piece suggests Pfizer's massive revenue base and efficiency gains make it a better choice.Yahoo3 Unpopular Stocks with Warning SignsThree stocks—Twilio, AGCO, and Integer Holdings—have bearish price targets, with Twilio's target at $263.04, AGCO's at $124.73, and Integer's at $121.80. Twilio's revenue growth of 14.7% and AGCO's five-year EPS contraction of 5.5% are cited as concerns.American Banking and Market NewsFinancial Comparison: Sensus Healthcare (NASDAQ:SRTS) versus Integer (NYSE:ITGR)Sensus Healthcare and Integer are compared across dividends, institutional ownership, risk, earnings, profitability, valuation, and analyst ratings. Integer beats Sensus on 9 of 14 factors, with higher revenue and earnings, but Sensus has a stronger consensus rating and higher upside. Analysts favor Sensus despite Integer's profitability.Simply Wall StIs Integer Holdings (ITGR) Fully Valued As Its Share Price Momentum Builds?Integer Holdings shares closed at $126.45, with a 90-day gain of 35.39% and year-to-date gain of 64.69%. Analysts peg fair value at $101, implying overvaluation, while a DCF model values the stock at $168.83, suggesting undervaluation. The conflicting valuations leave investors weighing earnings expectations against future cash flows.MorningstarAre LFCR, ITGR, FHB, INDV Obtaining Fair Deals for their Shareholders?Halper Sadeh LLC is investigating Lifecore Biomedical, Integer Holdings, First Hawaiian, and Indivior Pharmaceuticals for potential securities law violations and fiduciary breaches. The firm claims insiders may receive substantial benefits not available to ordinary shareholders and is seeking increased consideration or additional disclosures on a contingent fee basis.MorningstarACT NOW - The M&A Class Action Firm Is Investigating the Merger — FHB, INDV, ITGR, and LNTHMonteverde & Associates PC is investigating mergers and acquisitions for First Hawaiian, Indivior, Integer Holdings, and Lantheus. The firm claims to have recovered millions for shareholders and is seeking free consultations. No specific outcomes or timelines are disclosed.Business Wire BlogSHAREHOLDER ALERT: Kaskela Law Announces Probe into $127.00 Per Share Buyout Offer – Fair or Inadequately Low Price for Integer (ITGR) Shares?Kaskela Law is investigating the adequacy of Integer Holdings' $127-per-share cash buyout by KKR-affiliated funds, announced August 3, 2026. The probe seeks to determine whether the price is fair and whether officers breached fiduciary duties or violated securities laws.Investing.comInteger Holdings CHRO Kirk Thor sells $3.98m in company stock By Investing.comKirk Thor, CHRO of Integer Holdings, sold 31,540 shares over two days on September 14-15, 2026, totaling $3,981,725. He now holds 7,153 shares, and the stock traded near its 52-week high of $126.80, up 61% year-to-date.Ticker ReportHBK Investments L P Invests $14.50 Million in Integer Holdings Corporation $ITGRHBK Investments L P purchased 155,186 shares of Integer Holdings Corporation in Q2, valued at about $14.5 million. Analysts have a consensus "Hold" rating with an average target price of $109.86. The company reported Q2 EPS of $1.60, beating estimates.Markets DailyInteger Holdings Corporation (NYSE:ITGR) Receives $109.86 Average Price Target from AnalystsAnalysts rate Integer Holdings a Hold with an average price target of $109.86. The company reported Q2 EPS of $1.60, beating estimates, but revenue fell 2.6% year-over-year. Insider Andrew Senn sold 9,408 shares at $126.30.